Beijing, China

Jianzhuang Miao

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: Jianzhuang Miao: Innovator in Cancer Treatment

Introduction

Jianzhuang Miao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in cancer treatment.

Latest Patents

Jianzhuang Miao holds a patent for "Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist." This patent discloses an imidazo [2, 1-f] [1, 2, 4] triazin-4-amine derivative, or a stereoisomer thereof, which is useful as a TLR7 agonist. The patent also includes a pharmaceutical composition comprising this compound and outlines a method for treating cancer using the derivative or its stereoisomers.

Career Highlights

Jianzhuang Miao is currently associated with Beigene, Ltd., a leading biotechnology company focused on molecularly targeted and immuno-oncology drug discovery. His work at Beigene has positioned him as a key player in the development of innovative cancer therapies.

Collaborations

He collaborates with notable colleagues, including Guoliang Zhang and Changyou Zhou, who contribute to his research and development efforts in the pharmaceutical field.

Conclusion

Jianzhuang Miao's innovative work in cancer treatment through his patented compounds showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against cancer, and his collaborations further enhance the impact of his research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…